28/120
1.2 / 5 stars
All 120 Win/Lose results shown below
PTN Roast Me summary
PALATIN TECHNOLOGIES INC (PTN). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LosePTN / S&P -38.06% / 15.20% |
LosePTN / S&P PTN unavailable / 15.00% |
LosePTN / S&P PTN unavailable / 50.40% |
| 2026-Q11/3 |
WinPTN / S&P 13.26% / -4.33% |
LosePTN / S&P PTN unavailable / 11.30% |
LosePTN / S&P PTN unavailable / 27.70% |
| 2025-Q41/3 |
WinPTN / S&P 94.19% / 2.65% |
LosePTN / S&P PTN unavailable / 9.00% |
LosePTN / S&P PTN unavailable / 13.40% |
| 2025-Q31/3 |
WinPTN / S&P 13.14% / 8.12% |
LosePTN / S&P PTN unavailable / 4.61% |
LosePTN / S&P PTN unavailable / 13.45% |
| 2025-Q20/3 |
LosePTN / S&P -75.86% / 10.94% |
LosePTN / S&P -100.00% / 4.83% |
LosePTN / S&P PTN unavailable / 10.63% |
| 2025-Q10/3 |
LosePTN / S&P -47.75% / -4.27% |
LosePTN / S&P PTN unavailable / 4.98% |
LosePTN / S&P PTN unavailable / 10.57% |
| 2024-Q41/3 |
WinPTN / S&P 24.72% / 2.41% |
LosePTN / S&P PTN unavailable / 5.25% |
LosePTN / S&P PTN unavailable / 6.15% |
| 2024-Q30/3 |
LosePTN / S&P -54.36% / 5.89% |
LosePTN / S&P -60.85% / 5.89% |
LosePTN / S&P PTN unavailable / 6.11% |
| 2024-Q20/3 |
LosePTN / S&P 4.28% / 4.28% |
LosePTN / S&P -7.49% / 5.38% |
LosePTN / S&P PTN unavailable / 5.12% |
| 2024-Q11/3 |
LosePTN / S&P -53.02% / 10.56% |
WinPTN / S&P 52.80% / 5.71% |
LosePTN / S&P PTN unavailable / 5.59% |
| 2023-Q42/3 |
WinPTN / S&P 163.58% / 11.69% |
WinPTN / S&P 146.20% / 6.81% |
LosePTN / S&P PTN unavailable / 7.78% |
| 2023-Q31/3 |
LosePTN / S&P -28.10% / -3.27% |
WinPTN / S&P 179.53% / 7.52% |
LosePTN / S&P PTN unavailable / -5.03% |
| 2023-Q21/3 |
LosePTN / S&P -23.64% / 8.74% |
WinPTN / S&P 230.53% / 9.50% |
LosePTN / S&P PTN unavailable / -8.57% |
| 2023-Q11/3 |
LosePTN / S&P 7.42% / 7.50% |
WinPTN / S&P 342.48% / 10.77% |
LosePTN / S&P PTN unavailable / -15.69% |
| 2022-Q41/3 |
LosePTN / S&P -56.76% / 7.56% |
WinPTN / S&P 286.68% / 11.88% |
LosePTN / S&P PTN unavailable / -17.99% |
| 2022-Q31/3 |
LosePTN / S&P -15.43% / -4.88% |
WinPTN / S&P 739.73% / 13.47% |
LosePTN / S&P PTN unavailable / -1.41% |
| 2022-Q20/3 |
LosePTN / S&P -39.13% / -16.10% |
LosePTN / S&P PTN unavailable / 13.71% |
LosePTN / S&P PTN unavailable / 11.04% |
| 2022-Q10/3 |
LosePTN / S&P -9.80% / -4.60% |
LosePTN / S&P PTN unavailable / 15.97% |
LosePTN / S&P PTN unavailable / 42.23% |
| 2021-Q41/3 |
WinPTN / S&P 15.91% / 11.03% |
LosePTN / S&P PTN unavailable / 15.00% |
LosePTN / S&P PTN unavailable / 96.40% |
| 2021-Q30/3 |
LosePTN / S&P -27.87% / 0.58% |
LosePTN / S&P PTN unavailable / 10.77% |
LosePTN / S&P PTN unavailable / 69.42% |
| 2021-Q20/3 |
LosePTN / S&P -11.59% / 8.55% |
LosePTN / S&P -259.84% / 6.58% |
LosePTN / S&P PTN unavailable / 51.81% |
| 2021-Q10/3 |
LosePTN / S&P 1.47% / 6.17% |
LosePTN / S&P -100.60% / -1.06% |
LosePTN / S&P PTN unavailable / 7.39% |
| 2020-Q41/3 |
WinPTN / S&P 44.68% / 12.15% |
LosePTN / S&P -100.75% / -3.72% |
LosePTN / S&P PTN unavailable / -33.42% |
| 2020-Q30/3 |
LosePTN / S&P -7.84% / 8.93% |
LosePTN / S&P -100.44% / -2.04% |
LosePTN / S&P PTN unavailable / -27.10% |
| 2020-Q21/3 |
WinPTN / S&P 21.43% / 20.54% |
LosePTN / S&P -99.80% / -0.46% |
LosePTN / S&P -162.50% / -27.11% |
| 2020-Q11/3 |
LosePTN / S&P -46.15% / -19.60% |
WinPTN / S&P 192.38% / 3.47% |
LosePTN / S&P PTN unavailable / -14.75% |
| 2019-Q41/3 |
LosePTN / S&P -14.29% / 9.07% |
WinPTN / S&P 103.89% / 5.36% |
LosePTN / S&P PTN unavailable / 2.99% |
| 2019-Q32/3 |
LosePTN / S&P -21.55% / 1.70% |
WinPTN / S&P 50.05% / 5.02% |
WinPTN / S&P 325.00% / 0.21% |
| 2019-Q22/3 |
WinPTN / S&P 18.37% / 4.30% |
LosePTN / S&P -10.18% / 6.64% |
WinPTN / S&P 33.33% / 8.65% |
| 2019-Q11/3 |
WinPTN / S&P 38.03% / 13.65% |
LosePTN / S&P -79.91% / 8.12% |
LosePTN / S&P -106.06% / 14.29% |
| 2018-Q40/3 |
LosePTN / S&P -29.00% / -13.52% |
LosePTN / S&P -71.71% / 9.05% |
LosePTN / S&P -96.77% / 18.23% |
| 2018-Q30/3 |
LosePTN / S&P 3.09% / 7.71% |
LosePTN / S&P -57.24% / 10.21% |
LosePTN / S&P -83.33% / 19.06% |
| 2018-Q20/3 |
LosePTN / S&P -11.01% / 3.43% |
LosePTN / S&P 0.00% / 9.03% |
LosePTN / S&P 0.00% / 14.46% |
| 2018-Q12/3 |
WinPTN / S&P 26.74% / -0.76% |
WinPTN / S&P 850.02% / 7.68% |
LosePTN / S&P PTN unavailable / 12.46% |
| 2017-Q41/3 |
WinPTN / S&P 30.30% / 6.64% |
LosePTN / S&P PTN unavailable / 7.03% |
LosePTN / S&P PTN unavailable / 13.82% |
| 2017-Q31/3 |
WinPTN / S&P 53.49% / 4.48% |
LosePTN / S&P PTN unavailable / 5.68% |
LosePTN / S&P PTN unavailable / 17.57% |
| 2017-Q21/3 |
WinPTN / S&P 30.30% / 3.09% |
LosePTN / S&P PTN unavailable / 4.83% |
LosePTN / S&P PTN unavailable / 17.74% |
| 2017-Q10/3 |
LosePTN / S&P -35.29% / 6.07% |
LosePTN / S&P PTN unavailable / 3.67% |
LosePTN / S&P PTN unavailable / 13.32% |
| 2016-Q40/3 |
LosePTN / S&P -19.05% / 3.82% |
LosePTN / S&P PTN unavailable / 2.09% |
LosePTN / S&P PTN unavailable / 7.05% |
| 2016-Q31/3 |
WinPTN / S&P 43.18% / 3.85% |
LosePTN / S&P PTN unavailable / 0.20% |
LosePTN / S&P PTN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | PTN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 4.15% | 20.78% |
| Annualized return | 4.15% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | PTN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.23% | 83.14% |
| Annualized return | -55.36% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | PTN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.30% | 319.30% |
| Annualized return | -33.46% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |